ABSTRACT
INTRODUCTION
Lyme disease is a tick-borne multisystemic illness caused by the spirochete Borrelia burgdorferi sensu lato (4, 13) . Diagnosis of the causal agent has relied on conventional immunological methods, such as enzyme-linked immunosorbent assay (ELISA) and immunofluoresence assay (IFA) (3, 5) . These methods appear to lack sensitivity, yielding occasional false-positive and false-negative results (12) . Recently, several groups, including ours, have used the polymerase chain reaction (PCR) to detect spirochetal DNA in various biological fluids from Lyme disease patients (6, 8, 16, 18, 19, 21) . This approach required the identification of amplified DNA products on agarose gels, followed, in some cases, by a hybridization step to improve the specificity of the amplification assay. To simplify the procedure for testing large numbers of samples, and to provide a convenient format for clinical microbiology laboratories, we developed a solid-phase sandwich hybridization system readily applicable to the detection of PCR products. It relies on the use of a specific capture oligonucleotide covalently linked to microplate wells and also of a specific polybiotinylated detection probe. Amplified DNA, sandwiched between these two molecules, is then detected using streptavidin-conjugated horseradish peroxidase and a colorimetric substrate. This system has been tested on amplified DNA from various B. burgdorferi strains, from related or unrelated species and on clinical specimens. The new method proved very specific, sensitive and userfriendly.
MATERIALS AND METHODS

Bacteria, Clinical Specimens and DNA Isolation from Samples
Borrelia, Helicobacter pyloriand Mycobacterium strains were maintained in culture according to methods described elsewhere (7, 8, 10) . Genomic DNA from all bacterial strains was extracted as previously described (14) . DNA concentrations were determined spectrophotometrically by measuring the absorbance at 260 nm (15) . The genomic DNA was heated for 10 min at boiling point just before the PCR assay. Urine, serum, cerebrospinal fluid, synovial fluid and skin biopsy from patients suspected of having Lyme disease were obtained from various hospitals or general practitioners in Belgium. One milliliter of a mixture of biological fluids (urine, serum, synovial fluid and cerebrospinal fluid) was centrifuged for 10 min at 12 000 ×g , and the pellet was washed three times with 1 mL of phosphate-buffered saline solution (140 mM NaCl, 2.68 mM KCl, 8.09 mM Na 2 HPO 4 . 2H 2 O, 1.47 mM KH 2 PO 4 , pH 7.2). The pellet was then resuspended in 10 µ L of distilled water and incubated for 10 min at 100°C in a water bath. The skin biopsy sample (about 10 mm 3 ) was dropped into 100 µ L of amplification buffer (10 mM Tris-HCl, 1.5 mM MgCl 2 , 50 mM KCl, pH 8.3) supplemented with proteinase K at a final concentration of 2 mg/mL and incubated overnight at 50°C. The enzyme was inactivated by incubating at 100°C for 10 min on a thermal block. A volume of 10 µ L of the prepared clinical specimens was used in the PCR amplifications.
Synthetic Primers and Probes
Specific primers were used to amplify a 308-bp sequence from the ospA gene, located on the linear 49-kb plasmid and present in a large number of isolates belonging to B. burgdorferi sensu lato species (14, 20) . Oligonucleotide primers and probes were synthesized using the solid-phase phosphoramidite method (2,17) on an Applied Biosystems Model 394 Synthe sizer (Perkin-Elmer/Applied Biosystems, Rotterdam, The Netherlands). The sequences of the primers allowing the amplification of a 308-bp DNA fragment within the ospAgene have been already described (8) . The oligonucleotide used for detection carried a multi-fork-like structure on its 5 ′ end and bore 8 biotins (9) . The covalent bond of the capture probe to polystyrene has been described previously (9) . The sequences of capture (5 ′ -GCATGTAAGCAAAATGTTAGCAG -CCTTGA-3 ′ ) and detection (5 ′ -GGG-AAGCTTGAGCTTAAAGGAACTTC-3 ′ ) probes used in the hybridization assay were derived from the amplified 308-bp sequence.
PCR Assay
Conditions for the specific B. burgdorferi sensu lato PCR assay have been described previously (8) and used here with minor modifications. In summary, the PCR was performed with a Perkin-Elmer Model 480 DNA Thermal Cycler (Norwalk, CT, USA). Taq DNA polymerase (2.5 units per test), dNTPs (0.8 mM) and the reaction buffer were used as recommended by the supplier (Boehringer Mannheim Biochemica, Mannheim, Germany). Each primer was used at final concentration of 0.4 µ M. DNA samples (10 µ L) were amplified for 45 cycles under the following conditions: 94°C for 1 min, 72°C for 30 s and 63°C for 1 min. The resulting PCR mixture (10 µ L) was analyzed by 2% agarose gel electrophoresis and stained with ethidium bromide. DNA cross-contamination was minimized through the use of physical containment.
Detection System
The detection system ( Figure 1 ) was based on the hybridization of a target DNA (previously amplified by PCR) with a capture oligonucleotide, covalently linked onto the surface of an activated microplate (9). The hybridized DNA was then recognized by a multifork-like oligonucleotidic probe carrying 8 biotin groups (9) .
For one reaction, 10 µ L of the PCR mixture were treated with 40 µ L of 0.25 M NaOH for 10 min. This chemically denatured PCR product was mixed with 50 µ L of a Tris-buffered solution (0.1 M Tris-HCl, 1 M NaCl, 2 mM MgCl 2 , 0.05% Triton ® X-100, pH 7.5) containing 5% non-fat dried milk, 0.2 M acetic acid and 4 pmol of the detection probe. All of the PCR mixtures were tested in duplicate using a 96-well plate carrying the specific capture probe. To allow the capture of the PCR products, the microplate was incubated for 90 min at 37°C under slight agitation. The wells were then washed five times with 250 µ L of the Tris-buffered solution containing 5% non-fat dried milk. To detect hybridized target DNA, we added 100 µ L of streptavidin-horseradish peroxidase (DAKO, Copenhagen, Denmark), diluted one thousandfold in the Tris-buffered solution containing 3% of bovine serum albumin. After 20 min of incubation at room temperature, the wells were washed 5 times with 250 µ L of the Tris-buffered solution and incubated for 15 min in the dark with 200 µ L of 3,3 ′ ,5,5 ′ -tetramethylbenzidine (TMB). The reaction was then stopped by adding 100 µ L 5% sulfuric acid. The optical density at 450 nm (OD 450 ) was measured with a microplate reader (Novapath ™; Bio-Rad, Nazareth Eke, Belgium).
RESULTS AND DISCUSSION
Specificity of the Detection System
To evaluate the specificity of the detection system, assays were run on DNA isolated from three B. burgdorferi sensu lato strains belonging to the three known genospecies involved in Lyme disease ( B. burgdorferi IPI sensu stricto strain, B. garinii ZQI strain and B. 
Sensitivity of the Detection System
The sensitivity of the detection system was assessed by using amplification products from PCR assays performed on tenfold serial dilutions of DNA (10 pg to 1 fg, corresponding to about 10 000 to 1 genome equivalent) purified from the B. burgdorferi sensu stricto IPI strain. The results were compared with those obtained by agarose gel analysis of the same samples. The data indicated that all samples gave an OD 450 ≥ 3.0 with the detection system (Figure 2A) , whereas the response obtained with the same samples by agarose gel analysis decreased according to the quantity of DNA template ( Figure 2C) . A colorimetric signal lower than the cutoff value (OD 450 = 0.080) was observed with a dilution corresponding to 0.1 genome of B. burgdorferi sensu stricto IPI (data not shown). On the basis of these data, the equivalent of a single B. burgdorferi genome was clearly detected by the detection system.
The sensitivity of the detection system was also estimated by using tenfold serial dilutions of the amplified mixture, in which 1 pg of DNA template from the B. burgdorferisensu stricto IPI strain was added before the amplification process. This serial dilution test of the amplified DNA was analyzed both on agarose gel electrophoresis ( Figure 2D ) and on the detection system ( Figure 2B ). The results showed that the detection limit reached 1/1000 dilution on the colorimetric detection system (OD 450 = 0.120; cutoff = 0.080), whereas it reached 1/10 dilution on agarose gel electrophoresis. This clearly indicated that the detection system was more sensitive (100-fold) than the commonly used laboratory detection assay of PCR products. This level of sensitivity correlated with other studies using a similar detection system (1, 11) . However, our procedure seems to be more sensitive, probably due to the use of a multi-biotinylated detection probe.
Colorimetric Detection of Amplified DNA from Clinical Specimens
To evaluate the performance of the detection system, we analyzed PCR assays performed on clinical specimens (serum, 17; urine, 30; cerebrospinal fluid, 5; synovial fluid, 5; and skin biopsy, 8) collected from neuroborreliosis patients ( n= 45) and from patients suffering from unrelated diseases ( n= 20). All specimens from Lyme disease patients gave a positive result with an OD 450 greater (ranging from 0.320 to 3.0) than the cutoff value (OD 450 = 0.085), while the 20 specimens from other patients were negative, with an OD 450 (ranging from 0.057 to 0.075) lower than the cutoff value.
CONCLUSION
We recently reported the use of PCR primers for the specific detection of the B. burgdorferi sensu lato species, based on the selective amplification of a 308-bp fragment of the OspAgene (8). Here we described a detection procedure designed for the analysis of the amplified products that combines a sandwich hybridization assay with an ELISA-like detection system.
The detection procedure is highly specific and sensitive for B. burgdorferi sensu lato DNA, and it can be applied to a large variety of clinical specimens (urine, serum, synovial fluid, cerebrospinal fluid and skin biopsy). In addition, the amplification reaction, combined with a hybridization-detection assay that involves hybridization with two oligonucleotides internal to the target DNA, improves specificity and ensures that the correct PCR product is effectively detected. This additional level of specificity resolves ambiguities that may appear with PCR assay. The system presented also has the advantage that it provides numeric data, thus eliminating subjective interpretation.
Colorimetric detection can be performed in less than three hours and does not require toxic chemical agents, or radioisotopes and electrophoresis apparatus. In addition, the detection system can be adapted for automation, making its implementation in routine diagnostic laboratories a feasible prospect. Furthermore, this colorimetric detection system can be adapted easily for the detection of amplified DNA originating from sources other than B. burgdorferi .
